Profil
Luc Tanguay formerly worked at Theratechnologies, Inc., as President, CEO & Non-Independent Director from 2012 to 2020, Valeo Management LP, as Chairman, and Ambrilia Biopharma, Inc., as Director from 2006 to 2010.
Mr. Tanguay received his undergraduate degree in 1982 and graduate degree in 1984 from the University of Sherbrooke.
Anciens postes connus de Luc Tanguay
| Sociétés | Poste | Fin |
|---|---|---|
| THERATECHNOLOGIES INC. | Directeur Général | 06/04/2020 |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel treatments for viral diseases and cancer | Directeur/Membre du Conseil | 31/03/2010 |
Valeo Management LP
Valeo Management LP Miscellaneous Commercial ServicesCommercial Services Offers research commercialization services | Président | - |
Formation de Luc Tanguay
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Theratechnologies, Inc.
Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
University of Sherbrooke
University of Sherbrooke Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel treatments for viral diseases and cancer | Health Technology |
Valeo Management LP
Valeo Management LP Miscellaneous Commercial ServicesCommercial Services Offers research commercialization services | Commercial Services |
















